Publications | UCSF Philip R. Lee Institute for Health Policy Studies

Commentary: An Analysis of Medicare Reimbursement for Neurosurgeon Office Visits: 2010 Compared to 2018.

DiGiorgio AM, Menger RP

Neurosurgery 2021 Jul doi: 10.1093/neuros/nyab172

Basement membrane degradation and inflammation play a role in the pulmonary hemorrhage induced by a P-III snake venom metalloproteinase.

Castro AC, Escalante T, Rucavado A, Gutiérrez JM

Toxicon 2021 Jul doi: 10.1016/j.toxicon.2021.04.012

Practice and market factors associated with provider volume of health information exchange.

By: Apathy NC, Vest JR, Adler-Milstein J, Blackburn J, Dixon BE, Harle CA

J Am Med Inform Assoc 2021 Jul doi: 10.1093/jamia/ocab024

Author Response: Blood Biomarkers of Traumatic Brain Injury and Cognitive Impairment in Older Veterans.

Peltz CB, Yaffe K

Neurology 2021 Jul doi: 10.1212/WNL.0000000000012256

Humanism Before Heroism in Medicine.

Sarkar U, Cassel C

JAMA 2021 Jul doi: 10.1001/jama.2021.9569

Multi-System Inflammatory Syndrome in a Child Mimicking Kawasaki Disease.

Gupta A, Gill A, Sharma M, Garg M

J Trop Pediatr 2021 Jul doi: 10.1093/tropej/fmaa060

Reviews in environmental health: How systematic are they?

Sutton P, Chartres N, Rayasam SDG, Daniels N, Lam J, Maghrbi E, Woodruff TJ

Environ Int 2021 Jul doi: 10.1016/j.envint.2021.106473

Leukemia Risk in a Cohort of 3.9 Million Children with and without Down Syndrome.

Marlow EC, Ducore J, Kwan ML, Cheng SY, Bowles EJA, Greenlee RT, Pole JD, Rahm AK, Stout NK, Weinmann S, Smith-Bindman R, Miglioretti DL

J Pediatr 2021 Jul doi: 10.1016/j.jpeds.2021.03.001

Delayed Visits for Contraception Due to Concerns Regarding Pelvic Examination Among Women with History of Intimate Partner Violence.

Holt HK, Sawaya GF, El Ayadi AM, Henderson JT, Rocca CH, Westhoff CL, Harper CC

J Gen Intern Med 2021 Jul doi: 10.1007/s11606-020-06334-8

Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial.

Burns DK, Alexander RC, Welsh-Bohmer KA, Culp M, Chiang C, O'Neil J, Evans RM, Harrigan P, Plassman BL, Burke JR, Wu J, Lutz MW, Haneline S, Schwarz AJ, Schneider LS, Yaffe K, Saunders AM, Ratti E, TOMMORROW study investigators

Lancet Neurol 2021 Jul doi: 10.1016/S1474-4422(21)00043-0